Fieldpoint Private Securities’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$10K Sell
650
-680
-51% -$11.1K ﹤0.01% 735
2022
Q1
$26K Sell
1,330
-470
-26% -$8.39K 0.01% 774
2021
Q4
$31K Buy
1,800
+750
+71% +$12.8K 0.01% 738
2021
Q3
$18K Hold
1,050
﹤0.01% 849
2021
Q2
$16K Buy
1,050
+385
+58% +$4.82K ﹤0.01% 875
2021
Q1
$8K Buy
665
+565
+565% +$6.83K ﹤0.01% 1064
2020
Q4
$1K Buy
+100
New +$1.08K ﹤0.01% 1414

Other funds holding INVA

Fieldpoint Private Securities's INVA Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its Innoviva (INVA) stake by 51% in Q2 2022, selling an estimated $11.1K and leaving 650 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #735.

Fieldpoint Private Securities first reported a position in INVA in Q4 2020 and has held it in 7 quarters since. The position peaked at $31K in Q4 2021. 218 funds tracked by Wall St. Rank hold INVA as of Q2 2022.

  • Fieldpoint Private Securities held 650 shares of Innoviva worth $10K as of Q2 2022.
  • Fieldpoint Private Securities sold 680 Innoviva shares in Q2 2022, an estimated $11.1K.
  • Innoviva made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #735 holding.
  • Fieldpoint Private Securities first reported a position in Innoviva in Q4 2020 and has held it in 7 quarters since.
  • Fieldpoint Private Securities's Innoviva position peaked at $31K in Q4 2021.
  • 218 funds tracked by Wall St. Rank held Innoviva as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.